Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 1/20 | 0.46 |
| ▸ | REN | P00797 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19861966 | 0.91 | OPRM1 (0.50) | — | |
| SCHEMBL19862065 | 0.91 | OPRM1 (0.50) | — | |
| SCHEMBL17413459 | 0.89 | REN (0.48) | CCKBRREN | |
| SCHEMBL23680153 | 0.83 | REN (0.53) | CCKBRREN | |
| SCHEMBL17413437 | 0.83 | REN (0.53) | CCKBRREN | |
| SCHEMBL17553458 | 0.83 | PAX8 (0.52) | CCKBRREN | |
| SCHEMBL21627147 | 0.82 | CTSL (0.51) | — | |
| SCHEMBL16870006 | 0.82 | CTSL (0.51) | — | |
| SCHEMBL21627096 | 0.81 | CTSL (0.54) | — | |
| SCHEMBL16862485 | 0.81 | CTSL (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3160985-B1 | PROCESS FOR THE PRODUCTION OF D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE | FLAMMA SPA (IT) | 2021-07-28 | — | — | EP | disclosed |
| US-20170152289-A1 | PROCESS FOR THE PRODUCTION OF D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE | FLAMMA S.P.A. (IT) | 2017-06-01 | — | — | US | disclosed |
| WO-2016001042-A1 | PROCESS FOR THE PRODUCTION OF D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE | FLAMMA S.P.A. (IT) | 2016-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170152289-A1 | PROCESS FOR THE PRODUCTION OF D-ARGINYL-2,6-DIMETHYL-L-TYROSYL-L-LYSYL-L-PHENYLALANINAMIDE | ARG2, ARGLU1, ABAT | CCKBR 4043/4885REN 1017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.